Moleculin Biotech, Inc. 10-Q

ITEM 5. OTHER INFORMATION.    None.   19 Table of Contents   ITEM 6. EXHIBITS    Exhibit No.   Description       10.1   At Market Issuance Sales Agreement, dated June 25, 2021, by and among the Company and Oppenheimer & Co. Inc. (incorporated by reference to exhibit 1.1 of the Company's Form 8-K filed June 25, 2021)       10.2   Purchase Agreement dated June 25, 2021 by and between Moleculin Biotech, Inc. and Lincoln Park Capital Fund, LLC (incorporated by reference to exhibit 10.1 of the Company's Form 8-K filed June 25, 2021)       10.3   Registration Rights Agreement dated June 25, 2021 by and between Moleculin Biotech, Inc. and Lincoln Park Capital Fund, LLC (incorporated by reference to exhibit 10.2 of the Company's Form 8-K filed June 25, 2021)       10.4* +   Amendment No. 4 to Patent and Technology License Agreement, dated June 15, 2021, between the Parties dated April 2, 2012, as previously amended by Amendment No. 1 dated October 19, 2015 and Amendment No. 2 dated November 1, 2018, and Amendment No. 3 dated May 20, 2020       10.5*   Form of Indemnification Agreement between Moleculin Biotech, Inc. and its officers and directors       31.1*   Certification of Principal Executive Officer Pursuant to Section 302 of Sarbanes-Oxley Act of 2002       31.2*   Certification of Principal Financial Officer Pursuant to Section 302 of Sarbanes-Oxley Act of 2002       32.1*   Certification of Principal Executive Officer Pursuant to Section 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002       32.2*   Certification of Principal Accounting and Financial Officer Pursuant to Section 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002       101.INS*   Inline XBRL Instance Document (the Instance Document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document)        101.SCH*   Inline XBRL Taxonomy Extension Schema Document       101.CAL*   Inline XBRL Taxonomy Extension Calculation Linkbase Document       101.DEF*   Inline XBRL Taxonomy Extension Definition Linkbase Document       101.LAB*   Inline XBRL Taxonomy Extension Label Linkbase Document       101.PRE*   Inline XBRL Taxonomy Extension Presentation Linkbase Document       104   Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)   * Filed herewith. +    Pursuant to Item 601(b)(10)(iv) of Regulation S-K promulgated by the SEC, certain portions of this exhibit have been redacted. The Company hereby agrees to furnish supplementally to the SEC, upon its request, an unredacted copy of this exhibit.   20 Table of Contents   SIGNATURES   Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.     MOLECULIN BIOTECH, INC.       Date: August 11, 2021 By: /s/ Walter V. Klemp     Walter V. Klemp,     Chief Executive Officer and Chairman (Principal Executive Officer)       Date: August 11, 2021 By: /s/ Jonathan P. Foster     Jonathan P. Foster,     Executive Vice President & Chief Financial Officer (Principal Financial and Accounting Officer)     21